S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Roku stock and the mother of all entry opportunities
Strange change at your bank (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Strange change at your bank (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Roku stock and the mother of all entry opportunities
Strange change at your bank (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Strange change at your bank (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Roku stock and the mother of all entry opportunities
Strange change at your bank (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Strange change at your bank (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Roku stock and the mother of all entry opportunities
Strange change at your bank (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Strange change at your bank (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard

LAVA Therapeutics (LVTX) Short Interest Ratio & Short Volume

$2.04
+0.08 (+4.08%)
(As of 02/22/2024 ET)

LAVA Therapeutics Short Interest Data

Current Short Volume
87,700 shares
Previous Short Volume
9,200 shares
Change Vs. Previous Month
+853.26%
Dollar Volume Sold Short
$146,459.00
Short Interest Ratio / Days to Cover
0.1
Last Record Date
January 31, 2024
Float Size
12,240,000 shares
Short Percent of Float
0.72%
Today's Trading Volume
76,815 shares
Average Trading Volume
1,366,656 shares
Today's Volume Vs. Average
6%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling LAVA Therapeutics ?

Sign up to receive the latest short interest report for LAVA Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LVTX Short Interest Over Time

LVTX Days to Cover Over Time

LVTX Percentage of Float Shorted Over Time


LAVA Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202487,700 shares $146,459.00 +853.3%0.7%0.1 $1.67
1/15/20249,200 shares $15,364.00 +15.0%0.1%0.3 $1.67
12/31/20238,000 shares $12,640.00 -27.3%0.1%0.2 $1.58
12/15/202311,000 shares $17,160.00 -9.8%0.1%0.4 $1.56
11/30/202312,200 shares $18,492.76 -28.7%0.1%0.4 $1.52
11/15/202317,100 shares $25,480.71 -21.6%0.1%0.6 $1.49
10/31/202321,800 shares $25,942.00 -25.3%0.2%0.7 $1.19
10/15/202329,200 shares $40,588.00 -20.4%0.3%1.4 $1.39
9/30/202336,700 shares $53,949.00 -3.2%0.3%1.4 $1.47
9/15/202337,900 shares $64,759.73 -15.0%0.3%1.1 $1.71
8/31/202344,600 shares $78,942.00 +34.7%0.4%0.7 $1.77
8/15/202333,100 shares $59,580.00 -32.0%0.3%0.1 $1.80
7/31/202348,700 shares $91,556.00 -45.2%0.4%0.1 $1.88
7/15/202388,900 shares $176,022.00 +95.4%0.8%0.1 $1.98
6/30/202345,500 shares $92,365.00 -50.7%0.5%0.1 $2.03
6/15/202392,300 shares $180,908.00 +709.7%0.9%0.1 $1.96
5/31/202311,400 shares $21,660.00 -46.2%0.1%0 $1.90
5/15/202321,200 shares $40,280.00 +50.4%0.2%0.4 $1.90
4/30/202314,100 shares $21,291.00 +95.8%0.2%0.2 $1.51
4/15/20237,200 shares $12,816.00 -30.1%0.1%0.1 $1.78
3/31/202310,300 shares $17,098.00 -40.1%0.1%0.2 $1.66
3/15/202317,200 shares $29,584.00 +177.4%0.2%0.3 $1.72
2/28/20236,200 shares $13,888.00 +40.9%0.1%0.1 $2.24
2/15/20234,400 shares $14,872.00 -17.0%0.0%0.1 $3.38
1/31/20235,300 shares $19,292.00 +35.9%0.0%0.2 $3.64
1/15/20233,900 shares $15,015.00 -38.1%0.0%0.1 $3.85
12/30/20226,300 shares $22,050.00 +34.0%0.0%0.1 $3.50
12/15/20224,700 shares $18,142.00 -78.3%0.0%0 $3.86
11/30/202221,700 shares $119,567.00 +130.9%0.1%0 $5.51
11/15/20229,400 shares $50,196.00 No Change0.0%0 $5.34
10/31/20229,400 shares $40,702.00 +213.3%0.0%0 $4.33
10/15/20223,000 shares $11,880.00 -98.1%0.0%0 $3.96
9/30/2022158,800 shares $725,716.00 +14,336.4%1.7%0.2 $4.57
9/15/20221,100 shares $2,574.00 -31.3%0.0%0 $2.34
8/31/20221,600 shares $4,080.00 -36.0%0.0%0.3 $2.55
8/15/20222,500 shares $6,275.00 -30.6%0.0%0.3 $2.51
7/31/20223,600 shares $9,360.00 +71.4%0.0%0.4 $2.60
7/15/20222,100 shares $5,544.00 +2,000.0%0.0%0.3 $2.64
6/30/2022100 shares $295.00 -85.7%N/A0 $2.95
6/15/2022700 shares $1,995.00 -30.0%0.0%0.1 $2.85













LVTX Short Interest - Frequently Asked Questions

What is LAVA Therapeutics' current short interest?

Short interest is the volume of LAVA Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 87,700 shares of LVTX short. 0.72% of LAVA Therapeutics' shares are currently sold short. Learn More on LAVA Therapeutics' current short interest.

Which institutional investors are shorting LAVA Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of LAVA Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for LAVA Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.72% of LAVA Therapeutics' floating shares are currently sold short.

Is LAVA Therapeutics' short interest increasing or decreasing?

LAVA Therapeutics saw a increase in short interest in January. As of January 31st, there was short interest totaling 87,700 shares, an increase of 853.3% from the previous total of 9,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is LAVA Therapeutics' float size?

LAVA Therapeutics currently has issued a total of 0 shares. Some of LAVA Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. LAVA Therapeutics currently has a public float of 12,240,000 shares.

How does LAVA Therapeutics' short interest compare to its competitors?

0.72% of LAVA Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to LAVA Therapeutics: ADC Therapeutics SA (5.37%), GH Research PLC (4.59%), Grifols, S.A. (2.96%), NLS Pharmaceutics Ltd. (0.41%), Pharvaris (1.41%), Taro Pharmaceutical Industries Ltd. (0.99%), Tiziana Life Sciences Ltd (0.29%), American Oncology Network, Inc. (0.42%), Check-Cap Ltd. (1.18%), Editas Medicine, Inc. (14.95%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short LAVA Therapeutics stock?

Short selling LVTX is an investing strategy that aims to generate trading profit from LAVA Therapeutics as its price is falling. LVTX shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against LAVA Therapeutics?

A short squeeze for LAVA Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LVTX, which in turn drives the price of the stock up even further.

How often is LAVA Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LVTX, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:LVTX) was last updated on 2/23/2024 by MarketBeat.com Staff